Investing.com - Financial Markets Worldwide
⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Philippines gives FDA emergency use powers for COVID-19 drugs, vaccines

Published 12/02/2020, 05:13 PM
Updated 12/02/2020, 05:20 PM
© Reuters

MANILA, Dec 2 (Reuters) - Philippines President Rodrigo
Duterte issued an executive order on Wednesday granting the Food
and Drug Administration (FDA) the power to clear COVID-19 drugs
and vaccine for emergency use.
The Philippines wants to start immunizing 25 million people
next year against the coronavirus, hoping to restore some
normalcy after nearly nine months of at times harsh
restrictions, and prevent the economy from sinking deeper into
recession.
The FDA can now grant emergency use authorization (EUA) if
there is reason to believe the drug or vaccine may be effective
in preventing, diagnosing or treating COVID-19 and if their
potential benefits outweigh possible risks.
EUAs shall also be issued if there is "no adequate, approved
and available alternative to the drug or vaccine".
The national procurer or the public health programme
implementer can apply for the EUA, said the order.
The Philippines, which has the second most number of
confirmed coronavirus cases and deaths in Southeast Asia, is
racing to lock in vaccine supplies as it targets to immunize a
third of it 108 million population.
The Philippines has been in talks with at least four vaccine
makers about supply deals and has so far secured more than two
million COVID-19 shots from AstraZeneca.
The British drugmaker's vaccine still has to be approved by
regulators.

Latest comments

Loading next article…
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.